PharMerica Mountain LLC v. Arizona Rehab Campus LLC

CourtDistrict Court, D. Arizona
DecidedMay 26, 2022
Docket4:20-cv-00493
StatusUnknown

This text of PharMerica Mountain LLC v. Arizona Rehab Campus LLC (PharMerica Mountain LLC v. Arizona Rehab Campus LLC) is published on Counsel Stack Legal Research, covering District Court, D. Arizona primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
PharMerica Mountain LLC v. Arizona Rehab Campus LLC, (D. Ariz. 2022).

Opinion

1 WO 2

8 IN THE UNITED STATES DISTRICT COURT 9 FOR THE DISTRICT OF ARIZONA 10

11 PharMerica Mountain LLC, No. CV-20-00493-TUC-RM 12 Plaintiff, ORDER 13 v. 14 Arizona Rehab Campus LLC, 15 Defendant. 16

17 Pending before the Court is Plaintiff’s Motion to Strike Defendant’s Supplemental 18 Expert Disclosure. (Doc. 57.)1 Defendant responded in opposition (Doc. 71) and Plaintiff 19 replied (Doc. 72). For the following reasons the Motion to Strike will be granted. 20 I. Background 21 This action alleging breach of contract and related claims arises out of Defendant 22 Arizona Rehab Campus’s (“Defendant” or “Arizona Rehab Campus”) alleged failure to 23 pay Plaintiff PharMerica Mountain LLC (“Plaintiff” or “PharMerica”) for pharmacy 24 goods and services acquired pursuant to a Pharmacy Services Agreement. (See Doc. 1.) 25 Plaintiff alleges that Defendant owes approximately $775,000 in outstanding payments, 26 as well as approximately $83,000 for pharmacy goods and services that it acquired 27

28 1 Also pending are the parties’ Motions for Partial Summary Judgment (Docs. 58, 60), which will be resolved separately. 1 without intending to pay for them. (See id.) Defendant filed a counterclaim for 2 approximately $60,000. (See Doc. 6.) 3 The instant dispute involves a supplemental expert report that Defendant disclosed 4 on November 12, 2021, the date that discovery closed. (See Docs. 57, 71.) Defendant 5 timely disclosed Glassman’s original expert report on August 23, 2021. (Doc. 35; Doc. 6 57 at 2.) Plaintiff timely served its rebuttal expert disclosure on September 23, 2021. 7 (Doc. 47; Doc. 57 at 2.) On October 25, 2021, the Court denied Plaintiff’s Motion to 8 Exclude Glassman Testimony, stating that the Motion was premature as discovery had 9 not yet concluded and Glassman had not been deposed. (Doc. 53.) Plaintiff deposed 10 Glassman on November 10, 2021. (Doc. 57 at 3.) Defendant produced Glassman’s 11 supplemental expert report that is the subject of this dispute on November 12, 2021. (Id.) 12 The supplemental report analyzes additional documents that Glassman received on 13 November 11, 2021. (Id.; see also Doc. 57-1.) The supplemental report states that 14 Glassman’s review of the additional documents “confirms the accuracy” of Glassman’s 15 original August 23, 2021 report and that the additional documents reviewed for the 16 supplemental report “have no impact whatsoever” on the findings in the original report. 17 (Doc. 57-1.) However, the supplemental report contains at least six new opinions not 18 contained in the original report. (See Doc. 57 at 8-9; Doc. 57-1.) Furthermore, the “new” 19 information Glassman reviews in the supplemental report was available to Defendant 20 either before or shortly after Glassman prepared her original report and was available 21 prior to Glassman’s deposition. (See Doc. 57 at 6, Doc. 71 at 4-7.) The only two exhibits 22 Glassman reviews in the supplemental report that Plaintiff did not produce to Defendant 23 before Glassman’s original report are (1) PharMerica’s contract with MedImpact, 24 produced on October 21, 2021, and (2) PharMerica’s point-of-sale data for every 25 prescription drug ordered by Arizona Rehab, including which payor(s) a claim was 26 submitted to, dates of submission, and the result of same (the “POS Data”), produced on 27 September 17, 2021. (Doc. 57 at 2, 7-8.) 28 1 Plaintiff argues that the supplemental expert report should be excluded because (1) 2 it is untimely; (2) it is not a “supplemental” report within the meaning of Fed. R. Civ. P. 3 26(e); and (3) the untimely expert disclosure is not substantially justified or harmless. 4 (Doc. 57.) First, Plaintiff argues that the supplemental report is untimely because it was 5 disclosed over two months after the expiration of the expert disclosure deadline of 6 August 23, 2021 and after Plaintiff deposed Glassman. (Id. at 5.) Second, Plaintiff argues 7 that the supplemental report is not actually “supplemental” within the meaning of Rule 8 26(e) because (1) it refers to material and documents that Glassman’s original report did 9 not consider but that were available to Defendant at the time of Glassman’s original 10 report and (2) the supplemental report merely strengthens or deepens the original report. 11 (Id. at 5-9.) Plaintiff admits that the supplemental report reviews a few documents that 12 Plaintiff produced after Glassman prepared her original report; however, those documents 13 were produced prior to Glassman’s deposition and Defendant has offered no explanation 14 for why it did not provide Glassman with the documents before her deposition to enable 15 her to produce the supplemental report sooner. (Id. at 6-8.) Plaintiff argues that the 16 disclosure of the supplemental report after Glassman’s deposition leaves Plaintiff no 17 opportunity to question her about the findings in the supplemental report. (Id. at 6-8.) 18 Lastly, Plaintiff argues that the untimely expert disclosure is not substantially justified or 19 harmless because (1) the late disclosure prejudices Plaintiff and (2) Defendant could 20 have, but did not, produce the supplemental report earlier and has provided no reason 21 why it did not. (Id. at 10-13.) 22 In response, Defendant argues that (1) it made a good-faith effort to obtain all 23 documents during discovery and therefore it should not be faulted for any delays in doing 24 so; (2) its decision to provide Glassman with data and documents subsequent to her 25 deposition was the result of Defendant’s ignorance regarding what was contained within 26 certain files and was informed by “clues” that came to light during Glassman’s 27 deposition; (3) delays in the discovery process are the result of Defendant’s comparative 28 lack of understanding of the pharmaceutical industry and its lack of awareness that 1 certain documents would have been useful for Glassman to review earlier; and (4) 2 applicable law permits the disclosure of the supplemental expert report at this stage of the 3 case. (Doc. 71.) Defendant asks that a determination of the admissibility of the 4 supplemental expert report be deferred until a Daubert2 hearing. 5 In reply, Plaintiff contends first that the Motion is ripe for decision and need not 6 be delayed until a Daubert hearing. (Doc. 72.) Next, it argues that Defendant’s claimed 7 ignorance does not justify its lack of diligence in the discovery process, specifically its 8 failure to seek, identify, or provide information in a timely manner. (Id. at 2-6.) Plaintiff 9 argues that Defendant is now improperly attempting to shift the blame for its failure to 10 properly request, identify, and review the documents it needed onto Plaintiff. (Id. at 3-6.) 11 II. Applicable Law 12 A party must disclose a written report for any witness who will provide expert 13 testimony. The report must contain: 14 (i) a complete statement of all opinions the witness will express and the basis and reasons for them; 15 (ii) the facts or data considered by the witness in forming 16 them; (iii) any exhibits that will be used to summarize or support 17 them; 18 (iv) the witness’s qualifications, including a list of all publications authored in the previous 10 years; 19 (v) a list of all other cases in which, during the previous 4 20 years, the witness testified as an expert at trial or by deposition; and 21 (vi) a statement of the compensation to be paid for the study 22 and testimony in the case. 23 Fed. R. Civ. P. 26(a)(2)(B). Additionally, parties have a duty to supplement reports and 24 disclosures under Fed. R. Civ. P. 26(e). That rule states: 25 (1) In General.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Goodman v. Staples the Office Super-Store, LLC
644 F.3d 817 (Ninth Circuit, 2011)
Mason v. George
24 F. Supp. 3d 1254 (M.D. Georgia, 2014)
Plumley v. Mockett
836 F. Supp. 2d 1053 (C.D. California, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
PharMerica Mountain LLC v. Arizona Rehab Campus LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/pharmerica-mountain-llc-v-arizona-rehab-campus-llc-azd-2022.